Assessing the Impact of Concomitant Therapies on Anemia in Dialysis Patients

Assessing the Impact of Concomitant Therapies on Anemia in Dialysis Patients

Identification: nnj_mj00A6
Issue: May-June 2000
Volume: Vol. 27, No. 3

Standard: $30.00

Description

This article is available to members for free.

Goal: The goal of this CE offering is to provide the leaner with information about varying types of anemia, as well as discuss the causative etiology of hyporesponse to Epoetin alfa in patients receiving replacement therapy.

Objectives:

  1. Discuss the factors contributing to hyporesponse to anemia therapy in ESRD patients.
  2. Identify mechanisms of altered red cell production.
  3. Describe nursing interventions to enhance anemia therapy.


Note: This article is supported by a financial grant from Amgen, Inc. This article has undergone peer review. The information in this article does not necessarily reflect the opinions of ANNA or the sponsor.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.